Medizinische Hochschule Hannover : MHH Insight

Strengthening the virus defence with larch extract and more exercise

MHH study investigates the influence of prostaglandin E2 on the immune system.

Prepared for the future: MHH puts new logistics centre into operation

Central location, state-of-the-art technology and standardised processes

Biological heart chamber from the laboratory

BMBF funds MHH project on heart support system with three million euros

Dr. Simon Krooss (left) and Dr. Patrick Behrendt pipetting at a sterile workbench in a cell culture laboratory at MHH.

MHH receives around one million euros for the development of antiviral therapies

Volkswagen Foundation funds research projects on SARS-CoV-2 and hepatitis E.

Professor Behrens (left) and Professor Förster in the MHH Institute of Immunology with vaccine vials of the companies AstraZeneca and Biontech/Pfizer held crosswise.

MHH study on SARS-CoV-2: Cross-vaccination protects effectively

Combination of vaccines from AstraZeneca and Biontech/Pfizer protects particularly well - even with virus variants.

Professors Thomas Illig (left) and Markus Cornberg (right) in the biobank; Copyright: Karin Kaiser / MHH

MHH project "COVID-19 cohort" helps clarify disease risk

International research network discovers genetic markers for severe COVID-19 progression.

MHH fills important gap in lung research

For the first time, a team of scientists clearly demonstrates the existence of lipofibroblasts in human luectron microscope

MHH: New test to make gene therapy safer

SAGA detects tumour potential of viral vectors for blood stem cells

Finally, it's starting! "REBIRTH active school" gets pupils moving

Primary schools around Hanover, Wolfsburg, Gifhorn and Helmstedt start with the exercise programme for the sustainable promotion of children's health

How useful are COVID vaccinations for children?

Children between the ages of 12 and 17 can be vaccinated. But the STIKO does not recommend it. This is what our lung specialist Dr. Schwerk thinks ...